Literature DB >> 15540667

Listen to the patient: quality of life of patients with recently diagnosed malignant cord compression in relation to their disability.

P Levack1, J Graham, J Kidd.   

Abstract

Quality of life (QOL) was determined using the shortened version of the Schedule for the Evaluation of Individual Quality of Life (SEIQoL-Dw), in 180 patients, shortly after a diagnosis of malignant cord compression. The median SEIQoL score was 66 (maximum 100). Twenty-five per cent of patients had a score >83. SEIQoL correlated with KPS (P<0.004) but the range of scores for each level of performance was very wide. Although there was an association between SEIQoL and ability to walk, the difference was small and not significant. SEIQoL was adversely affected by emotional distress as measured using HAD (P<0.01), although few patients were identified as being severely depressed. The findings are a reminder that QOL as determined by the patient may not coincide with health professionals' opinions.

Entities:  

Mesh:

Year:  2004        PMID: 15540667     DOI: 10.1191/0269216304pm925oa

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  10 in total

Review 1.  The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW.

Authors:  L Wettergren; A Kettis-Lindblad; M Sprangers; L Ring
Journal:  Qual Life Res       Date:  2009-06-03       Impact factor: 4.147

Review 2.  Rehabilitation and treatment of spinal cord tumors.

Authors:  Vishwa S Raj; Latanya Lofton
Journal:  J Spinal Cord Med       Date:  2013-01       Impact factor: 1.985

3.  Losing sight of the wood for the trees: some issues in describing and valuing health, and another possible approach.

Authors:  Paul Dolan; Henry Lee; Tessa Peasgood
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

Review 4.  A review of the application, feasibility, and the psychometric properties of the individualized measures in cancer.

Authors:  Ala' S Aburub; Nancy E Mayo
Journal:  Qual Life Res       Date:  2016-11-18       Impact factor: 4.147

5.  Self-generated Domains of Quality of Life in Children with and Without Cerebral Palsy.

Authors:  Judith Vinson; Laura Shank; Pamela Dixon Thomas; Seth Warschausky
Journal:  J Dev Phys Disabil       Date:  2010-10-01

6.  Inpatient rehabilitation outcomes in patients with malignant spinal cord compression compared to other non-traumatic spinal cord injury: A population based study.

Authors:  Christian D Fortin; Jennifer Voth; Susan B Jaglal; B Catharine Craven
Journal:  J Spinal Cord Med       Date:  2015-01-23       Impact factor: 1.985

7.  Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.

Authors:  A M Giovannetti; E Pietrolongo; A Giordano; V Cimino; A Campanella; G Morone; A Fusco; A Lugaresi; P Confalonieri; F Patti; M G Grasso; M Ponzio; S Veronese; A Solari
Journal:  Qual Life Res       Date:  2016-04-28       Impact factor: 4.147

8.  Individual quality of life in chronic kidney disease: influence of age and dialysis modality.

Authors:  Khaled Abdel-Kader; Larissa Myaskovsky; Irina Karpov; Jay Shah; Rachel Hess; Mary Amanda Dew; Mark Unruh
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

9.  Suspected malignant cord compression - improving time to diagnosis via a 'hotline': a prospective audit.

Authors:  L Allan; L Baker; J Dewar; S Eljamel; R M Grant; J G Houston; T McLeay; A J Munro; P Levack
Journal:  Br J Cancer       Date:  2009-05-26       Impact factor: 7.640

Review 10.  Somatically ill persons' self-nominated quality of life domains: review of the literature and guidelines for future studies.

Authors:  Elsbeth F Taminiau-Bloem; Mechteld R M Visser; Carol Tishelman; Margot A Koeneman; Florence J van Zuuren; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2010-01-03       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.